CMS Adds New COVID-19 Clinical Trials Improvement Activity to the Quality Payment Program

CMS Adds New COVID-19 Clinical Trials Improvement Activity to the Quality Payment Program CMS issued a letter thanking clinicians for their ongoing efforts to treat patients and combat COVID-19 and shared additional details on the new Merit-Based Incentive Payment System (MIPS) improvement activity. As announced earlier this month, clinicians who participate in a COVID-19 clinical trial and report their findings to a clinical data repository or registry may now earn credit in MIPS under the Improvement Activities performance category for the 2020 performance period by attesting to this new activity. Letter

Centers for Medicare & Medicaid Services (CMS) has sent this Center for Medicare and Medicaid Innovation (CMMI) Update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.